tiprankstipranks
Trending News
More News >
Irhythm Technologies (IRTC)
NASDAQ:IRTC
US Market

Irhythm Technologies (IRTC) Stock Forecast & Price Target

Compare
589 Followers
See the Price Targets and Ratings of:

IRTC Analyst Ratings

Strong Buy
14Ratings
Strong Buy
12 Buy
2 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Irhythm
Technologies
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IRTC Stock 12 Month Forecast

Average Price Target

$218.08
▲(25.21% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Irhythm Technologies in the last 3 months. The average price target is $218.08 with a high forecast of $244.00 and a low forecast of $185.00. The average price target represents a 25.21% change from the last price of $174.17.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"86":"$86","245":"$245","125.75":"$125.8","165.5":"$165.5","205.25":"$205.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":244,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$244.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":218.08,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$218.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":185,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$185.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[86,125.75,165.5,205.25,245],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,182.74,187.4523076923077,192.1646153846154,196.87692307692308,201.58923076923077,206.30153846153846,211.01384615384615,215.72615384615386,220.43846153846152,225.15076923076924,229.8630769230769,234.57538461538462,239.2876923076923,{"y":244,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,182.74,185.45846153846153,188.1769230769231,190.89538461538461,193.61384615384617,196.3323076923077,199.05076923076925,201.76923076923077,204.48769230769233,207.20615384615385,209.9246153846154,212.64307692307693,215.3615384615385,{"y":218.08,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,182.74,182.91384615384615,183.08769230769232,183.26153846153846,183.43538461538463,183.60923076923078,183.78307692307692,183.9569230769231,184.13076923076923,184.30461538461537,184.47846153846154,184.6523076923077,184.82615384615386,{"y":185,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":87.9,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.17,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.85,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.16,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":106.88,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.59,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.65,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.95,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":164.97,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":171.08,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":167.45,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.3,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":182.74,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$244.00Average Price Target$218.08Lowest Price Target$185.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on IRTC
Truist Financial
Truist Financial
$230$215
Buy
23.44%
Upside
Reiterated
12/18/25
iRhythm price target lowered to $215 from $230 at TruistiRhythm price target lowered to $215 from $230 at Truist
Robert W. Baird Analyst forecast on IRTC
Robert W. Baird
Robert W. Baird
$235$220
Buy
26.31%
Upside
Reiterated
12/16/25
Robert W. Baird Remains a Buy on Irhythm Technologies (IRTC)
Canaccord Genuity Analyst forecast on IRTC
Canaccord Genuity
Canaccord Genuity
$212
Buy
21.72%
Upside
Reiterated
12/16/25
Analysts' Top Healthcare Picks: AxoGen (AXGN), Irhythm Technologies (IRTC)
Citi
$242
Buy
38.94%
Upside
Reiterated
12/11/25
Citi Keeps Their Buy Rating on Irhythm Technologies (IRTC)
Morgan Stanley Analyst forecast on IRTC
Morgan Stanley
Morgan Stanley
$195$205
Buy
17.70%
Upside
Reiterated
12/02/25
iRhythm price target raised to $205 from $195 at Morgan StanleyiRhythm price target raised to $205 from $195 at Morgan Stanley
Bank of America Securities Analyst forecast on IRTC
Bank of America Securities
Bank of America Securities
$225
Buy
29.18%
Upside
Reiterated
11/18/25
Confident Buy Rating for Irhythm Technologies Amidst LCD Concerns and Market Expansion Opportunities
BTIG
$215
Buy
23.44%
Upside
Reiterated
11/17/25
Confident Outlook for Irhythm Technologies Amid Proposed Medicare Policy Changes
Oppenheimer Analyst forecast on IRTC
Oppenheimer
Oppenheimer
$175$225
Buy
29.18%
Upside
Reiterated
10/31/25
iRhythm price target raised to $225 from $175 at OppenheimeriRhythm price target raised to $225 from $175 at Oppenheimer
J.P. Morgan Analyst forecast on IRTC
J.P. Morgan
J.P. Morgan
$190$240
Buy
37.80%
Upside
Reiterated
10/31/25
iRhythm price target raised to $240 from $190 at JPMorganiRhythm price target raised to $240 from $190 at JPMorgan
Needham
$244
Buy
40.09%
Upside
Reiterated
10/31/25
Irhythm Technologies: Strong Performance and Promising Growth Potential Justify Buy Rating
William Blair Analyst forecast on IRTC
William Blair
William Blair
Buy
Reiterated
10/31/25
iRhythm Technologies: Strong Growth and Strategic Initiatives Justify Buy Rating
Goldman Sachs Analyst forecast on IRTC
Goldman Sachs
Goldman Sachs
$180$202
Hold
15.98%
Upside
Reiterated
10/31/25
Goldman Sachs Keeps Their Hold Rating on Irhythm Technologies (IRTC)
Freedom Capital Markets Analyst forecast on IRTC
Freedom Capital Markets
Freedom Capital Markets
$205
Buy
17.70%
Upside
Initiated
10/13/25
Irhythm Technologies (IRTC) Receives a Buy from Freedom Capital Markets
Evercore ISI Analyst forecast on IRTC
Evercore ISI
Evercore ISI
$185
Hold
6.22%
Upside
Initiated
09/23/25
iRhythm initiated with an In Line at Evercore ISIiRhythm initiated with an In Line at Evercore ISI
Wells Fargo Analyst forecast on IRTC
Wells Fargo
Wells Fargo
$130$180
Buy
3.35%
Upside
Reiterated
08/01/25
Wells Fargo Remains a Buy on Irhythm Technologies (IRTC)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on IRTC
Truist Financial
Truist Financial
$230$215
Buy
23.44%
Upside
Reiterated
12/18/25
iRhythm price target lowered to $215 from $230 at TruistiRhythm price target lowered to $215 from $230 at Truist
Robert W. Baird Analyst forecast on IRTC
Robert W. Baird
Robert W. Baird
$235$220
Buy
26.31%
Upside
Reiterated
12/16/25
Robert W. Baird Remains a Buy on Irhythm Technologies (IRTC)
Canaccord Genuity Analyst forecast on IRTC
Canaccord Genuity
Canaccord Genuity
$212
Buy
21.72%
Upside
Reiterated
12/16/25
Analysts' Top Healthcare Picks: AxoGen (AXGN), Irhythm Technologies (IRTC)
Citi
$242
Buy
38.94%
Upside
Reiterated
12/11/25
Citi Keeps Their Buy Rating on Irhythm Technologies (IRTC)
Morgan Stanley Analyst forecast on IRTC
Morgan Stanley
Morgan Stanley
$195$205
Buy
17.70%
Upside
Reiterated
12/02/25
iRhythm price target raised to $205 from $195 at Morgan StanleyiRhythm price target raised to $205 from $195 at Morgan Stanley
Bank of America Securities Analyst forecast on IRTC
Bank of America Securities
Bank of America Securities
$225
Buy
29.18%
Upside
Reiterated
11/18/25
Confident Buy Rating for Irhythm Technologies Amidst LCD Concerns and Market Expansion Opportunities
BTIG
$215
Buy
23.44%
Upside
Reiterated
11/17/25
Confident Outlook for Irhythm Technologies Amid Proposed Medicare Policy Changes
Oppenheimer Analyst forecast on IRTC
Oppenheimer
Oppenheimer
$175$225
Buy
29.18%
Upside
Reiterated
10/31/25
iRhythm price target raised to $225 from $175 at OppenheimeriRhythm price target raised to $225 from $175 at Oppenheimer
J.P. Morgan Analyst forecast on IRTC
J.P. Morgan
J.P. Morgan
$190$240
Buy
37.80%
Upside
Reiterated
10/31/25
iRhythm price target raised to $240 from $190 at JPMorganiRhythm price target raised to $240 from $190 at JPMorgan
Needham
$244
Buy
40.09%
Upside
Reiterated
10/31/25
Irhythm Technologies: Strong Performance and Promising Growth Potential Justify Buy Rating
William Blair Analyst forecast on IRTC
William Blair
William Blair
Buy
Reiterated
10/31/25
iRhythm Technologies: Strong Growth and Strategic Initiatives Justify Buy Rating
Goldman Sachs Analyst forecast on IRTC
Goldman Sachs
Goldman Sachs
$180$202
Hold
15.98%
Upside
Reiterated
10/31/25
Goldman Sachs Keeps Their Hold Rating on Irhythm Technologies (IRTC)
Freedom Capital Markets Analyst forecast on IRTC
Freedom Capital Markets
Freedom Capital Markets
$205
Buy
17.70%
Upside
Initiated
10/13/25
Irhythm Technologies (IRTC) Receives a Buy from Freedom Capital Markets
Evercore ISI Analyst forecast on IRTC
Evercore ISI
Evercore ISI
$185
Hold
6.22%
Upside
Initiated
09/23/25
iRhythm initiated with an In Line at Evercore ISIiRhythm initiated with an In Line at Evercore ISI
Wells Fargo Analyst forecast on IRTC
Wells Fargo
Wells Fargo
$130$180
Buy
3.35%
Upside
Reiterated
08/01/25
Wells Fargo Remains a Buy on Irhythm Technologies (IRTC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Irhythm Technologies

1 Month
xxx
Success Rate
13/20 ratings generated profit
65%
Average Return
+1.47%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 65.00% of your transactions generating a profit, with an average return of +1.47% per trade.
3 Months
xxx
Success Rate
16/25 ratings generated profit
64%
Average Return
+8.89%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.00% of your transactions generating a profit, with an average return of +8.89% per trade.
1 Year
Richard NewitterTruist Financial
Success Rate
11/20 ratings generated profit
55%
Average Return
+33.68%
reiterated a buy rating 3 days ago
Copying Richard Newitter's trades and holding each position for 1 Year would result in 55.00% of your transactions generating a profit, with an average return of +33.68% per trade.
2 Years
xxx
Success Rate
18/20 ratings generated profit
90%
Average Return
+63.48%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +63.48% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IRTC Analyst Recommendation Trends

Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
23
21
33
21
23
Hold
5
5
6
5
5
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
28
26
39
27
29
In the current month, IRTC has received 23 Buy Ratings, 5 Hold Ratings, and 1 Sell Ratings. IRTC average Analyst price target in the past 3 months is 218.08.
Each month's total comprises the sum of three months' worth of ratings.

IRTC Financial Forecast

IRTC Earnings Forecast

Next quarter’s earnings estimate for IRTC is <$0.01 with a range of -$0.12 to $0.14. The previous quarter’s EPS was -$0.16. IRTC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year IRTC has Performed in-line its overall industry.
Next quarter’s earnings estimate for IRTC is <$0.01 with a range of -$0.12 to $0.14. The previous quarter’s EPS was -$0.16. IRTC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year IRTC has Performed in-line its overall industry.

IRTC Sales Forecast

Next quarter’s sales forecast for IRTC is $199.93M with a range of $199.00M to $203.09M. The previous quarter’s sales results were $192.88M. IRTC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year IRTC has Performed in-line its overall industry.
Next quarter’s sales forecast for IRTC is $199.93M with a range of $199.00M to $203.09M. The previous quarter’s sales results were $192.88M. IRTC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year IRTC has Performed in-line its overall industry.

IRTC Stock Forecast FAQ

What is IRTC’s average 12-month price target, according to analysts?
Based on analyst ratings, Irhythm Technologies’s 12-month average price target is 218.08.
    What is IRTC’s upside potential, based on the analysts’ average price target?
    Irhythm Technologies has 25.21% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is IRTC a Buy, Sell or Hold?
          Irhythm Technologies has a consensus rating of Strong Buy which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Irhythm Technologies’s price target?
            The average price target for Irhythm Technologies is 218.08. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $244.00 ,the lowest forecast is $185.00. The average price target represents 25.21% Increase from the current price of $174.17.
              What do analysts say about Irhythm Technologies?
              Irhythm Technologies’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of IRTC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.